Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Solid Tumors 481Solid Tumor 418Advanced Solid Tumor 409Unspecified Adult Solid Tumor, Protocol Specific 350Solid Tumors 322Mesothelioma, Malignant 281Mesothelioma 244Solid Tumor, Adult 113Carcinoma, Non-Small-Cell Lung 109Retinoblastoma 81Ovarian Neoplasms 65Lung Neoplasms 61Melanoma 56Sarcoma 52Stomach Neoplasms 50Carcinoma, Renal Cell 49Colorectal Neoplasms 46Small Cell Lung Carcinoma 45Pancreatic Neoplasms 45Esophageal Neoplasms 45Neoplasms 43Uterine Cervical Neoplasms 41Breast Neoplasms 38Advanced or Metastatic Solid Tumors 35Hematopoietic and Lymphatic System Neoplasm 34Neoplasm Metastasis 33Squamous Cell Carcinoma of Head and Neck 32Advanced Malignant Solid Tumors 31Solid Tumours 30Triple Negative Breast Neoplasms 29

Interventions

ivarmacitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Patients With Advanced Solid Tumors Who Discontinued Treatment Due to irAE × Other solid neoplasm × Clear all
NCT07313202 2025-12-31

Ivarmacitinib in Advanced Solid Tumors: A Prospective, Two-Cohort, Two-Phase Exploratory Study in Patients Discontinued Due to Immune Intolerance

Fujian Cancer Hospital

Phase 2 Not yet recruiting
72 enrolled
Other solid neoplasm

Patients With Advanced Solid Tumors Who Discontinued Treatment Due to irAE

Data powered by HemOnc (CC BY 4.0) Colophon âš¡